Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
Sign Up to like & getrecommendations! Published in 2023 at "Biomaterials science"
DOI: 10.1039/d2bm01996e
Abstract: Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-stage prognosis. The crucial obstacle in the treatment of GBM is the inability of chemo drugs or other anticancer medicines to reach brain tumors… read more here.
Keywords: gbm drug; multiforme gbm; drug delivery; glioblastoma multiforme ... See more keywords
EPCO-24. COMPUTATIONAL APPROACH TO IDENTIFYING NEUROINFLAMMATION IN GLIOBLASTOMA MULTIFORME (GBM)
Sign Up to like & getrecommendations! Published in 2020 at "Neuro-oncology"
DOI: 10.1093/neuonc/noaa215.303
Abstract: Glioblastoma multiforme (GBM) is an aggressive brain cancer with dismal prognosis, despite aggressive surgery, radiation and chemotherapy. Therapies directed to the immune system are an exciting prospect in oncology and require an understanding of the… read more here.
Keywords: gbm; glioblastoma multiforme; multiforme gbm; immune infiltration ... See more keywords
Abstract 2836: H2S donors as radiosensitizers for glioblastoma multiforme (GBM)
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-2836
Abstract: Glioblastoma multiforme (GBM) is an extremely aggressive CNS cancer in adults. Radiation is a cornerstone therapy but poses high risk of healthy tissue necrosis. Despite maximal treatment, GBM results in death within 15-21 months of… read more here.
Keywords: multiforme gbm; radiation; gbm; h2s ... See more keywords
GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)
Sign Up to like & getrecommendations! Published in 2018 at "Bioengineering"
DOI: 10.3390/bioengineering5040083
Abstract: Glioblastoma Multiforme (GBM) is a common primary brain cancer with a poor prognosis and a median survival of less than 14 months. Current modes of treatment are associated with deleterious side effects that reduce the… read more here.
Keywords: polo like; multiforme gbm; like kinase; glioblastoma multiforme ... See more keywords
Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14010262
Abstract: Simple Summary Glioblastoma multiforme (GBM) remains to be the most frequent malignant tumor of the central nervous system (CNS), which accounts for approximately 54% of all primary brain gliomas. Current treatment modalities for GBM include… read more here.
Keywords: glioblastoma multiforme; cell cycle; multiforme gbm; gbm ... See more keywords
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072116
Abstract: Simple Summary Glioblastoma multiforme is one of the hardest-to-treat brain tumors, often resistant to conventional treatments such as chemotherapy and radiation therapy. Despite advances in cancer research and treatment, the survival rate for glioblastoma patients… read more here.
Keywords: treatment options; resistance; multiforme gbm; gbm ... See more keywords